S2CID 7211864
Recent studies published in 2024 show an increased risk of NAION, particularly in patients using these drugs for weight loss
GLP-1RAs and Other Mechanisms According to the Global Burden of Disease 2019 data report, 68 although age-standardized mortality from chronic respiratory diseases has shown a gradual decline globally from 1990 to 2019, COPD still has the highest age-standardized mortality rate of all chronic respiratory diseases and COPD is also the largest burden of death from chronic respiratory diseases, a situation that may remain difficult to improve in the future
Originally used to treat type 2 diabetes, it is now approved for weight loss
The decision to begin offering GLP-1 or weight loss prescriptions comes after an increase in customer inquiries on weight-loss aid
81 A study in anxious dogs showed treatment with the probiotic yeast Saccharomyces boulardii, at 1 billion CFUs per kg of dog food daily for 35 days, decreased levels of cortisol, suggesting stress reduction